Trials / Completed
CompletedNCT01471223
Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study
Belatacept in Renal Transplantation: Analyses Using Data From the Collaborative Transplant Study (CTS)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 89 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to estimate the incidence rates of Post-transplant Lymphoproliferative Disorder (PTLD), malignancy and hospitalized infections in adult kidney-only transplant recipients treated with Belatacept, and compared the incidences to the incidences in those treated with Calcineurin inhibitor (CNI) based regimens at the time of transplantation.
Detailed description
Time Perspective: Prospective design, Retrospective data collection and analysis
Conditions
Timeline
- Start date
- 2012-03-31
- Primary completion
- 2017-08-08
- Completion
- 2017-08-08
- First posted
- 2011-11-15
- Last updated
- 2017-09-19
Source: ClinicalTrials.gov record NCT01471223. Inclusion in this directory is not an endorsement.